Skip to main content
Journal cover image

Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.

Publication ,  Journal Article
Singh, SN; Poole, J; Anderson, J; Hellkamp, AS; Karasik, P; Mark, DB; Lee, KL; Bardy, GH; SCD-HeFT Investigators,
Published in: Am Heart J
November 2006

BACKGROUND: Heart failure complicated by atrial fibrillation (AF) is associated with excessive mortality and morbidity. The aim of the study was to determine the role of amiodarone or implantable cardioverter/defibrillator (ICD) in patients with AF and heart failure. METHODS: Patients were determined to be in sinus rhythm (SR) or AF on the baseline electrocardiogram. Mortality, ICD discharge, or change in rhythm was assessed. RESULTS: Of the 2521 patients at baseline, 2328 were in SR and 173 were in AF. Overall, after adjusting for differences in baseline variables, there was no difference in mortality between patients with SR and patients with AF (P = .98), nor within assigned groups: placebo (P) (P = .82), amiodarone (A) (P = .68), and ICD (P = .40). For patients with SR, ICD decreased mortality (P vs ICD, P = .004; A vs ICD, P = .004; P vs A, P = .75). For patients with AF, there were no differences in mortality among groups (P vs ICD, P = .99; A vs ICD, P = .88; P vs A, P = .88). Of patients with SR at baseline, 11% (264) developed AF by any electrocardiogram during follow-up (P 12%, A 8%, ICD 15%; A vs P, P = .019; A vs ICD, P = .001; P vs ICD, P = .044). Of patients with AF, 70% (121) developed SR during follow-up (P 66%, A 67%, ICD 75%, all P = not significant against each other). Any ICD shock was seen in 52% (34) of patients with AF vs 30% (222) of patients with SR (P = .001). Inappropriate shocks were seen in 37% (24) of patients with AF vs 14% (107) of patients with SR (P = .001). Appropriate shocks were more often seen in AF vs SR (P = .03). CONCLUSION: After adjustments for baseline differences, patients with AF and patients with SR have similar overall mortality rates. Compared to P or A, ICD improves survival in patients with SR, but may not in patients with AF. Amiodarone is effective in reducing new AF, but not in converting AF to SR. Implantable cardioverter/defibrillator, inappropriate, and appropriate shocks were more often seen in AF than in SR.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2006

Volume

152

Issue

5

Start / End Page

974.e7 / 974.11

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Female
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anti-Arrhythmia Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Singh, S. N., Poole, J., Anderson, J., Hellkamp, A. S., Karasik, P., Mark, D. B., … SCD-HeFT Investigators, . (2006). Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J, 152(5), 974.e7-974.11. https://doi.org/10.1016/j.ahj.2006.08.012
Singh, Steven N., Jeannie Poole, Jill Anderson, Anne S. Hellkamp, Pamela Karasik, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, and Gust H. SCD-HeFT Investigators. “Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.Am Heart J 152, no. 5 (November 2006): 974.e7-974.11. https://doi.org/10.1016/j.ahj.2006.08.012.
Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, et al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J. 2006 Nov;152(5):974.e7-974.11.
Singh, Steven N., et al. “Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.Am Heart J, vol. 152, no. 5, Nov. 2006, pp. 974.e7-974.11. Pubmed, doi:10.1016/j.ahj.2006.08.012.
Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J. 2006 Nov;152(5):974.e7-974.11.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2006

Volume

152

Issue

5

Start / End Page

974.e7 / 974.11

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Female
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anti-Arrhythmia Agents